TELA Bio (TELA) Capital Expenditures (2018 - 2026)

TELA Bio's Capital Expenditures history runs 9 years deep, the most recent figure standing at $119000.0 for Q1 2026.

• In Q1 2026, Capital Expenditures rose 271.88% year-over-year to $119000.0; the TTM figure through Mar 2026 stood at $535000.0 (down 36.69% YoY), while the FY2025 annual figure was $448000.0, down 54.7% from the prior year.
• Capital Expenditures was $119000.0 for Q1 2026 at TELA Bio, down from $433000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $864000.0 in Q4 2022 to a low of -$190000.0 in Q2 2022.
• Historically, Capital Expenditures has averaged $178764.7 across 5 years, with a median of $119000.0 in 2026.
• Biggest YoY gain for Capital Expenditures was 1427.27% in 2022; the steepest drop was 860.0% in 2022.
• A 5-year view of Capital Expenditures shows it stood at $864000.0 in 2022, then sank by 76.27% to $205000.0 in 2023, then advanced by 28.78% to $264000.0 in 2024, then jumped by 64.02% to $433000.0 in 2025, then sank by 72.52% to $119000.0 in 2026.
• The last three Capital Expenditures figures came in at $119000.0 (Q1 2026), $433000.0 (Q4 2025), and -$131000.0 (Q3 2025), per Business Quant data.